Wire · opportunities
At-home injection version of Alzheimer's drug now available in US
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 9 September 2026 · Fusion42 review
The FDA has expanded approval for Leqembi Iqlik, an at-home injectable form of the Alzheimer’s drug Leqembi, allowing patients in the U.S. to start their early-stage treatment at home with weekly self-administration instead of hospital infusions.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
This shift hands you direct access to patients early in their Alzheimer’s journey without hospital logistics blocking uptake. Look to adapt your patient support and distribution to capitalise on this new home-care pathway.
◆ Coverage
1 source · 8 Sep 2026
◆ Related on Wire
◆ Topics
Biotechalzheimersdrug-deliveryFDA-approvalhome-carebiogeneisai